- cafead   Aug 01, 2024 at 12:02: PM
via AbbVie (ABBV) has completed its acquisition of Cerevel Therapeutics. Cerevel is now part of AbbVie. The acquisition is expected to be accretive to adjusted earnings per share beginning in 2030.
article source
article source